Neutrophils are a main source of circulating suPAR predicting outcome in critical illness

被引:48
作者
Gussen, Hendrik [1 ]
Hohlstein, Philipp [1 ]
Bartneck, Matthias [1 ]
Warzecha, Klaudia Theresa [1 ]
Buendgens, Lukas [1 ]
Luedde, Tom [1 ]
Trautwein, Christian [1 ]
Koch, Alexander [1 ]
Tacke, Frank [1 ,2 ]
机构
[1] RWTH Univ Hosp Aachen, Dept Med 3, D-52074 Aachen, Germany
[2] Charite Univ Med Ctr, Dept Hepatol Gastroenterol, Augustenburger Pl 1, D-13353 Berlin, Germany
关键词
CD87; Monocytes; Neutrophils; ICU; Organ failure; Sepsis; Prognosis; Biomarker; Innate immunity; PLASMINOGEN-ACTIVATOR RECEPTOR; UROKINASE RECEPTOR; RISK STRATIFICATION; MORTALITY; MARKER; EXPRESSION; MATURATION; DISEASE; UPAR; ILL;
D O I
10.1186/s40560-019-0381-5
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BackgroundCirculating levels of soluble urokinase plasminogen activation receptor (suPAR) have been proposed as a prognostic biomarker in patients with critical illness and sepsis. However, the origin of suPAR in sepsis has remained obscure. We investigated the potential cellular sources of suPAR by analyzing membrane-bound urokinase plasminogen activator receptor (uPAR, CD87) and evaluated its clinical relevance in critically ill patients.MethodsWe studied 87 critically ill patients (44 with sepsis, 43 without sepsis) from the medical intensive care unit (ICU) in comparison to 48 standard care patients with infections and 27 healthy controls in a prospective single-center non-interventional cohort study. Cellular uPAR expression of different immune cell subsets (by flow cytometry from peripheral blood) and corresponding serum suPAR concentrations were determined upon ICU admission and at day 3. Furthermore, we analyzed the effects of serum from sepsis patients on the activation and uPAR cleavage of primary human neutrophils and macrophages in vitro.ResultsIn healthy controls, uPAR (CD87) expression was detected on nearly all blood neutrophils and monocytes, but only scarcely on lymphocytes. While uPAR expression on monocytes was maintained in ICU patients, only 58% of neutrophils from critically ill patients expressed uPAR, which was significantly lower than in healthy controls or standard care patients. Concomitantly, serum suPAR levels were significantly increased in ICU patients. We noted a clear inverse correlation between low neutrophilic uPAR and high serum suPAR in standard care and ICU patients, indicating that shedding of uPAR from activated neutrophils represents a main source of suPAR in systemic inflammation. Both low uPAR and high suPAR were closely associated with mortality in critically ill patients. Furthermore, serum from sepsis patients induced uPAR protein expression and subsequent receptor shedding on isolated primary neutrophils, but not on macrophages, in vitro.ConclusionsThe inverse correlation between low uPAR surface expression on neutrophils and high serum suPAR in critically ill patients supports that neutrophils are a main source of shed suPAR proteins in systemic inflammation. Furthermore, high suPAR levels and low neutrophilic uPAR expression predict mortality in ICU patients.
引用
收藏
页数:11
相关论文
共 47 条
[1]   Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic review [J].
Backes, Yara ;
van der Sluijs, Koenraad F. ;
Mackie, David P. ;
Tacke, Frank ;
Koch, Alexander ;
Tenhunen, Jyrki J. ;
Schultz, Marcus J. .
INTENSIVE CARE MEDICINE, 2012, 38 (09) :1418-1428
[2]   Liposomal encapsulation of dexamethasone modulates cytotoxicity, inflammatory cytokine response, and migratory properties of primary human macrophages [J].
Bartneck, Matthias ;
Peters, Franziska Marie ;
Warzecha, Klaudia Theresa ;
Bienert, Michaela ;
van Bloois, Louis ;
Trautwein, Christian ;
Lammers, Twan ;
Tacke, Frank .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2014, 10 (06) :1209-1220
[3]   C-terminal proendothelin-1 (CT-proET-1) is associated with organ failure and predicts mortality in critically ill patients [J].
Buendgens, Lukas ;
Yagmur, Eray ;
Bruensing, Jan ;
Herbers, Ulf ;
Baeck, Christer ;
Trautwein, Christian ;
Koch, Alexander ;
Tacke, Frank .
JOURNAL OF INTENSIVE CARE, 2017, 5
[4]   Usefulness of suPAR in the risk stratification of patients with sepsis admitted to the emergency department [J].
Casagranda, Ivo ;
Vendramin, Chiara ;
Callegari, Tiziana ;
Vidali, Matteo ;
Calabresi, Alessandra ;
Ferrandu, Giovanna ;
Cervellin, Gianfranco ;
Cavazza, Mario ;
Lippi, Giuseppe ;
Zanotti, Isabella ;
Negro, Sophie ;
Rocchetti, Andrea ;
Arfini, Carlo .
INTERNAL AND EMERGENCY MEDICINE, 2015, 10 (06) :725-730
[5]  
Desmedt S., 2017, CRIT REV CLIN LAB SC, V13, P1
[6]   Soluble urokinase-type plasminogen activator receptor as a prognostic biomarker in critically ill patients [J].
Donadello, Katia ;
Scolletta, Sabino ;
Taccone, Fabio Silvio ;
Covajes, Cecilia ;
Santonocito, Cristina ;
Cortes, Diego Orbegozo ;
Grazulyte, Daiva ;
Gottin, Leonardo ;
Vincent, Jean-Louis .
JOURNAL OF CRITICAL CARE, 2014, 29 (01) :144-149
[7]   suPAR as a prognostic biomarker in sepsis [J].
Donadello, Katia ;
Scolletta, Sabino ;
Covajes, Cecilia ;
Vincent, Jean-Louis .
BMC MEDICINE, 2012, 10
[8]   CD87 as a marker for terminal granulocytic maturation: Assessment of its expression during granulopoiesis [J].
Elghetany, MT ;
Patel, J ;
Martinez, J ;
Schwab, H .
CYTOMETRY PART B-CLINICAL CYTOMETRY, 2003, 51B (01) :9-13
[9]   Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population [J].
Eugen-Olsen, J. ;
Andersen, O. ;
Linneberg, A. ;
Ladelund, S. ;
Hansen, T. W. ;
Langkilde, A. ;
Petersen, J. ;
Pielak, T. ;
Moller, L. N. ;
Jeppesen, J. ;
Lyngbaek, S. ;
Fenger, M. ;
Olsen, M. H. ;
Hildebrandt, P. R. ;
Borch-Johnsen, K. ;
Jorgensen, T. ;
Haugaard, S. B. .
JOURNAL OF INTERNAL MEDICINE, 2010, 268 (03) :296-308
[10]   suPAR: The unspecific marker for disease presence, severity and prognosis [J].
Eugen-Olsen, Jesper ;
Giamarellos-Bourboulis, Evangelos J. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2015, 46 :S33-S34